omalizumab - Removal Estimates

๐Ÿ’Š omalizumab

omalizumab Dialyzability By Different Modalities

MW: 145058.53
Protein Binding: N/A
Vd: 0.046 L/kg

๐Ÿ“Š Removal Estimates

Estimates based on drug properties and standard treatment parameters.

๐Ÿฉธ

Hemodialysis

32.4 mL/min
Poorly Dialyzable
Minimal removal expected. Half-life: 26 days. No supplementation needed. Despite long half-life, clearance is low due to other factors.
Data Used:
โœ… molar_mass, mw_factor, vd, vd_factor, half_life
โš ๏ธ Missing: protein_binding
Free fraction: 0.5 Mw factor: 0.2 Vd factor: 1 Hl factor: 1.2 Half life: 26 days Half life category: Extended (> 72h)
๐Ÿซ€

Peritoneal Dialysis

0.2 mL/min
Low PD Clearance
Minimal removal expected. No supplementation needed. Half-life: 26 days.
Data Used:
โœ… molar_mass, half_life
โš ๏ธ Missing: protein_binding
Free fraction: 0.5 Half life: 26 days Half life category: Extended (> 72h)
๐Ÿ”„

Plasmapheresis (TPE)

Unable to Assess
Insufficient data for TPE risk assessment. Protein binding and Vd required.
Data Used:
โœ… vd, half_life
โš ๏ธ Missing: protein_binding
Half life: 26 days Half life category: Extended (> 72h)
๐Ÿงช

Hemoadsorption

High Effectiveness
Excellent candidate for hemoperfusion. Long half-life suggests significant removal possible. Effective in overdose. Rebound expected.
Data Used:
โœ… vd, half_life
Half life: 26 days Half life category: Extended (> 72h)

๐Ÿ“‹ Summary of Estimates

Modality Clearance/Value Half-Life Classification Data Quality
Hemodialysis 32.4 mL/min 26 days Poorly Dialyzable Partial Data
Peritoneal Dialysis 0.2 mL/min 26 days Low PD Clearance Partial Data
Plasmapheresis (TPE) Unable to Assess 26 days N/A Partial Data
Hemoadsorption High Effectiveness 26 days N/A Complete Data

๐Ÿ“Œ Important Notes

Back to Drug Details